This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells.
Stem cells (Dayton, Ohio) · 2013
Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction.
Cell transplantation · 2013
Functional repair of human donor lungs by IL-10 gene therapy.
Science translational medicine · 2009
Latest funding
- $724,611
Fabry Disease: Mechanisms and Next-Generation Therapies
CIHR · 2012 · Nominated PI
- $2,450,000
The FACTs Project: FAbry disease Clinical research and Therapeutics
CIHR · 2011 · Nominated PI
- $1,950,000
CIHR Training Program in Regenerative Medicine
CIHR · 2008 · Co-investigator
4 publications.
Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells.
Yannarelli G, Pacienza N, Cuniberti L, Medin J, Davies J, Keating A
Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction.
Yannarelli G, Dayan V, Pacienza N, Lee CJ, Medin J, Keating A
Functional repair of human donor lungs by IL-10 gene therapy.
Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku M, Sato M, Medin J, Davidson BL, de Perrot M, Waddell TK, Slutsky AS, Keshavjee S
Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model.
Mattocks M, Bagovich M, De Rosa M, Bond S, Binnington B, Rasaiah VI, Medin J, Lingwood C
Fabry Disease: Mechanisms and Next-Generation Therapies
Principal investigators: Medin, Jeffrey A
Keywords: Fabry Disease; Gene Therapy; Kidney; Lentivirus; Lysosomal Storage Disorders; Microarray; Stroke
The FACTs Project: FAbry disease Clinical research and Therapeutics
Principal investigators: Medin, Jeffrey A
Keywords: Biomarker Discovery/Validation; Cell-Mediated Gene Therapy; Fabry Disease; Hematopoietic Stem Cells; Immune Outcomes; Lentivirus Vectors; Lysosomal Storage Disorders; Pilot Clinical Trial; Safety
CIHR Training Program in Regenerative Medicine
Principal investigators: Levy, Gary A
Keywords: Gene Therapy; Regenerative Medicine; Stem Cells; Tolerance; Transplantation
CIHR Strategic Training Grant in the Development of Biological Therapeutics
Principal investigators: Hampson, David R
Keywords: Antibodies; Breast Cancer; Cancer; Developmental Neurobiology; Drug Delivery; Drug Metabolism; Epilepsy; G-Protein Coupled Receptors; Immune System; Immunity; Infection; Liposomes; Nervous System; Ocular; Oncongenes; Parkinson'S Disease; Peptides; Pharmaceuticals; Radiopharmaceuticals; Regeneration; Retinoblastoma; Rnai; Sirna; Stem Cells
Molecular dynamics of the cell-surface proteome in primary prostate cancer cells: Towards a community resource for therapeutic intervention and biomarker discovery
Principal investigators: Kislinger, Thomas; Medin, Jeffrey A
Keywords: Bioinformatics; Biomarker; Cell-Surface Markers; Chemotherapy; Prostate Cancer; Proteomics
The Canadian Regenerative Medicine Network (CRM-Net) / Le Réseau Canadien de Médecine Régénérative
Principal investigators: Sefton, Michael
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Mingyao Liu and Marcelo Cypel: 94 shared papers
- Jeffrey Medin and Armand Keating: 2 shared papers
- Jeffrey Medin and Mingyao Liu: 1 shared paper
- Jeffrey Medin and Marcelo Cypel: 1 shared paper
- Mingyao Liu and Armand Keating: 1 shared paper
- Mechanical Engineering
- Thoracic Surgery
- Department of Surgery
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.